The Chinese Pharmacopoeia is updated every five years. The 2025 edition is the twelfth edition. It was promulgated by the NMPA and National Health Commission on March 26, 2025, and will take effect on October 1, 2025.
Provides the "rules of the road" for the entire pharmacopoeia, including 361 general testing methods, preparation requirements, and guidelines.
The Pharmacopoeia of the People’s Republic of China (ChP) is the official compendium of drugs, covering the standards for quality, preparation, and safety of medicines. For researchers, manufacturers, and regulators, accessing the Pharmacopoeia of the People's Republic of China PDF is essential for ensuring compliance with international pharmaceutical standards.
Meeting the strict legal requirements enforced by the NMPA for importing/exporting medicines.
The ChP is organized into four distinct volumes, each covering a specific category of pharmaceutical products and technical requirements: Announcement of the National Medical Products ... - NMPA pharmacopoeia of the people 39-s republic of china pdf
Accessing the official text of the ChP in PDF format requires caution due to strict copyright laws, intellectual property rights, and regulatory validation needs. Official vs. Unofficial Sources
Covers Western medicines, antibiotics, biological products, and chemical raw materials.
Pharmacopoeia Of The People 39-s Republic Of China Pdf Apr 2026
Compiled by the under the National Medical Products Administration (NMPA) of the People's Republic of China, the PPRC is a comprehensive compendium that includes standards for: Purity and description of active ingredients. Tests for identification and impurities. Dosage , potency, and safety measures. The Chinese Pharmacopoeia is updated every five years
Before delving into access methods, it is essential to understand the ChP's authoritative status. As outlined by the National Medical Products Administration (NMPA), the ChP forms a crucial part of China's national drug standards. It is not merely a reference text but a mandatory legal technical standard that all pharmaceutical activities—from research and development (R&D) to manufacturing, distribution, and clinical use—must follow. The legal framework ensures that once a new edition is promulgated, it supersedes older national standards for the drugs it covers, compelling manufacturers to update their processes and compliance documents to align with the latest requirements.
Authorized regulatory intelligence platforms provide searchable, updated digital access to the ChP texts.
: Lists general technical requirements, including testing methods for impurities, 42 guidelines for various drug forms, and standards for pharmaceutical excipients. How to Access PDF Versions
: Includes a total of 6,385 monographs , featuring 159 new additions and 1,101 revisions across its volumes. Provides the "rules of the road" for the
Covers Chinese crude drugs (materia medica), herbal extracts, and prepared slices, along with patent medicines.
The 2020 edition is organized into four volumes, encompassing over 5,900 total monographs, including dedicated volumes for TCM, chemical drugs, biological products, and general technical requirements.
: Continues to align with International Council for Harmonisation (ICH) guidelines (e.g., Q-series guidelines) to improve global drug standard competitiveness. Structure and Content